Who is in your network?

Revolutionizing Nutrition: The Evolution of the Ready-to-Use Therapeutic Food Market
According to FMI’s estimate of the global ready-to-use therapeutics market, the industry’s value is projected to be over US$ 429 million in 2023. FMI projects that by the conclusion of this forecast period, ready-to-use therapeutic food sales would have brought in around US$ 743.4 million in revenue globally.

Due to increased worldwide rates of malnutrition, undernutrition is thought to be a contributing factor in about 45% of deaths in the Under 5 age group. The demand for ready-to-use therapeutic food is rising globally as communities become more conscious of using current treatments to address the issue. An earlier analysis published in the American Journal of Clinical Nutrition found that 96% of the children had satisfactory nutritional health within a year of receiving RUTF treatment.

Visit to pick up a copy of the report sample :
https://www.futuremarketinsigh....ts.com/reports/sampl

Interestingly enough, the impact of the Covid-19 pandemic was drastic across the developing and underdeveloped worlds that benefitted the market after a short while. It was apprehended that severely malnourished children were at a dangerously high risk of contracting the novel coronavirus due to weakened immunity. So considerable efforts were made for the provisioning of ready-to-eat therapeutic foods boosting its sales in the global market.

However, higher costs and the absence of sufficient market channels are projected to impede the growth of RTE therapeutic food products throughout the forecast period. Many producers of RTD therapeutic products do not adhere to WHO’s food product preparation standards, resulting in microbial contamination.

Key Takeaways from the Ready-to-use Therapeutic Food Market Study Report

Based on market survey reports, the sales of ready-to-use therapeutic foods were dominated by the United States, with a revenue share of 23.5% in 2022.
Likewise, Germany is a leading contributor of RTD therapeutic products in the UNICEF programs and held a market share of 14.5% in 2022.
Contrastingly, Asia Pacific countries are performing well these days and have increased their ready-to-eat therapeutic food production capacity to compete globally. While the market for this commodity in China is projected to grow at 4.5% through 2033 India is expected to advance at a 6.5% growth rate.
Competitive Landscape for the Ready-to-use Therapeutic Food Market Players

Nuflower Foods, GC Rieber Compact AS, Valid Nutrition, InnoFaso Corp., Edesia Inc., Nutrivita Foods Ltd., Diva Nutritional Products, Insta Products Ltd., Mana Nutritive Aid Product Inc., Meds & Food for Kids Inc., Samil Industrial Co., Tabatchnick Fine Foods Inc., Amul India Inc., Hilina Enriched Foods PLC, and Société de Transformation Alimentaire among others are some key players in the global ready-to-use therapeutic food market.

For More Information Click Here :
https://www.futuremarketinsigh....ts.com/ask-question/

Industry Key Segment

By Type:

Solid Therapeutic Food
Power or Blend Form
Biscuits or Bar Form
Paste Therapeutic Food
Drinkable Therapeutic Food
Other Ready-to-use Therapeutic Foods